Glossary:TAG-00295-Rem-erp

Glossary > Remote SDV

Remote SDV
Tag-ID	TAG-00295-Rem-erp
English	Remote Source data verification / Remote Source document verification
EN Abbr.	SDV
French	Vérification des données sources à distance / Vérification des documents sources à distance
FR Abbr.	VDS
German	Quelldatenverifikation aus der Ferne / Quelldatenüberprüfung aus der Ferne / Remote Source Data Verification
DE Abbr.	SDV

References

	Scope	Document part	Language	Document
AUT FAQ - COVID-19 Studien 15-Mar-2021 -	G	-	DE	AUT FAQ - COVID-19 Studien 15-Mar-2021
DEU Empfehlungen des BfArM und des PEI zur Europäischen Guidance during COVID-19 v4 04-Feb-2021 -	G	-	DE	DEU Empfehlungen des BfArM und des PEI zur Europäischen Guidance during COVID-19 v4 04-Feb-2021
EU GUIDANCE ON THE MANAGEMENT OF CLINICAL TRIALS DURING THE COVID-19 (CORONAVIRUS) PANDEMIC v5 10-Feb-2022 11 d)	G	11 d)	EN	EU GUIDANCE ON THE MANAGEMENT OF CLINICAL TRIALS DURING THE COVID-19 (CORONAVIRUS) PANDEMIC v5 10-Feb-2022
EU GUIDANCE ON THE MANAGEMENT OF CLINICAL TRIALS DURING THE COVID-19 (CORONAVIRUS) PANDEMIC v5 10-Feb-2022 Annex 1	G	Annex 1	EN	EU GUIDANCE ON THE MANAGEMENT OF CLINICAL TRIALS DURING THE COVID-19 (CORONAVIRUS) PANDEMIC v5 10-Feb-2022
FRA Bonnes pratiques - CONTRÔLE QUALITÉ À DISTANCE DES ESSAIS CLINIQUES (CNIL) 16-May-2024 -	G	-	FR	FRA Bonnes pratiques - CONTRÔLE QUALITÉ À DISTANCE DES ESSAIS CLINIQUES (CNIL) 16-May-2024
GBR Making changes to a research study to manage the impact of COVID-19 12-Oct-2021 -	G	-	EN	GBR Making changes to a research study to manage the impact of COVID-19 12-Oct-2021
USA FDA Guidance for Industry - Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020 Q15	G	Q15	EN	USA FDA Guidance for Industry - Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020
USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 III B. 3.	G	III B. 3.	EN	USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013